Improving cancer risk prediction and early detection for colon and esophagus cancers
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
This study is working on new tests that can help find colon and esophagus cancers early, so patients can get better and faster screenings for these types of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10884387 on NIH RePORTER |
What this research studies
This research focuses on developing and validating biomarker assays that can help predict the risk of colon and esophagus cancers at an early stage. The project involves collaboration between various labs and institutions to ensure that these biomarker tests meet clinical standards. By integrating data and communication across different research centers, the goal is to enhance the discovery and validation processes for these important cancer biomarkers. Patients may benefit from more accurate and timely cancer screenings as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for colon or esophagus cancers, including those with a family history or other risk factors.
Not a fit: Patients who do not have risk factors for colon or esophagus cancers may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection methods for colon and esophagus cancers, potentially saving lives through earlier intervention.
How similar studies have performed: Previous research has shown promise in using biomarkers for cancer detection, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Grady, William Mallory — Fred Hutchinson Cancer Center
- Study coordinator: Grady, William Mallory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.